Fabino Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve 1. The Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fabino Enterprises (formerly Fabino Life Sciences) has informed the stock exchange that its Board of Directors will meet on Thursday, May 29, 2025. The main items on the agenda are approval of audited standalone and consolidated financial results for the half year and full year ended March 31, 2025. The Board will also appoint a new Secretarial Auditor (M/s. JNG & Co. LLP) and a new Internal Auditor (M/s. B B Gusani and Associates), both for FY 2025-26 and FY 2026-27. The trading window for dealing in the company's shares is currently closed and will reopen 48 hours after the meeting outcomes are announced. No financial numbers have been disclosed yet — those will come after the Board approves the results.
This is a routine advance notice of a results announcement, so no immediate stock price impact is expected. Shareholders should watch for the actual audited numbers (revenue, profit, margins) once released on or after May 29, as those will be the real triggers. The auditor appointments are standard governance actions and not a red flag on their own.